Amphastar Pharmaceuticals to Present at Annual Healthcare Conference

The biopharmaceutical company will showcase its pipeline and commercial progress at the 25th Annual Needham Healthcare Conference.

Apr. 6, 2026 at 11:08am

Got story updates? Submit your updates here. ›

Amphastar Pharmaceuticals, Inc., a California-based biopharmaceutical company focused on developing and commercializing injectable, inhalation, and intranasal products, announced that its CFO, EVP of Regulatory Affairs and Clinical Operations, and SVP of Corporate Communication will present at the 25th Annual Needham Healthcare Conference on April 14, 2026.

Why it matters

As a publicly traded pharmaceutical company, Amphastar's participation in high-profile industry conferences provides an opportunity to showcase its product pipeline, highlight commercial progress, and engage with investors and potential partners.

The details

Amphastar's presentation at the Needham Healthcare Conference will feature updates on the company's technical capabilities, regulatory affairs, and corporate communications initiatives. The webcast of the presentation will be available on Amphastar's investor relations website for 30 days following the event.

  • Amphastar will present at the 25th Annual Needham Healthcare Conference on Tuesday, April 14, 2026 at 11:45 am ET.
  • The webcast of the presentation will be available on Amphastar's website for 30 days following the event.

The players

Amphastar Pharmaceuticals, Inc.

A biopharmaceutical company that focuses on developing, manufacturing, and commercializing technically challenging generic and proprietary injectable, inhalation, and intranasal products.

Bill Peters

Chief Financial Officer of Amphastar Pharmaceuticals.

Tony Marrs

Executive Vice President of Regulatory Affairs and Clinical Operations at Amphastar Pharmaceuticals.

Dan Dischner

Senior Vice President of Corporate Communication at Amphastar Pharmaceuticals.

Got photos? Submit your photos here. ›

What’s next

The webcast of Amphastar's presentation at the Needham Healthcare Conference will be available on the company's investor relations website for 30 days following the event.

The takeaway

Amphastar's participation in the Needham Healthcare Conference demonstrates its commitment to engaging with the investment community and showcasing its pipeline of innovative pharmaceutical products.